694 results on '"Gerbes, Alexander L."'
Search Results
2. p70 Ribosomal Protein S6 Kinase Is a Checkpoint of Human Hepatic Stellate Cell Activation and Liver Fibrosis in Mice
3. Liver Injury Associated with Metamizole Exposure: Features of an Underestimated Adverse Event
4. To Protect Fatty Livers from Ischemia Reperfusion Injury: Role of Ischemic Postconditioning
5. Recent advances in the prevention and treatment of decompensated cirrhosis and acute-on-chronic liver failure (ACLF) and the role of biomarkers.
6. Pretreatment with zinc protects Kupffer cells following administration of microbial products
7. The inhibition of YAP Signaling Prevents Chronic Biliary Fibrosis in the Abcb4-/- Model by Modulation of Hepatic Stellate Cell and Bile Duct Epithelium Cell Pathophysiology
8. Antifibrotic effects of hypocalcemic vitamin D analogs in murine and human hepatic stellate cells and in the CCl4 mouse model
9. Erhöhte Leberwerte
10. Hepatitis C virus treatment in the real world: optimising treatment and access to therapies
11. The effects of hepatic steatosis on thromboxane A2 induced portal hypertension
12. Evaluating the best empirical antibiotic therapy in patients with acute-on-chronic liver failure and spontaneous bacterial peritonitis
13. Anschriften der Herausgeber und Autoren
14. Update on herbal and dietary supplement-induced liver injury: current gaps and future directions
15. Development and Validation of a Test to Identify Drugs That Cause Idiosyncratic Drug-Induced Liver Injury
16. Risk of recurrent hepatic encephalopathy in patients with liver cirrhosis: a German registry study
17. Predictors of ribociclib-mediated antitumour effects in native and sorafenib-resistant human hepatocellular carcinoma cells
18. The inhibition of YAP Signaling Prevents Chronic Biliary Fibrosis in the Abcb4-/- Model by Modulation of Hepatic Stellate Cell and Bile Duct Epithelium Cell Pathophysiology.
19. Transjugular intrahepatic portosystemic shunt for patients with liver cirrhosis: survey evaluating indications, standardization of procedures and anticoagulation in 43 German hospitals
20. Prognostic Significance and Functional Relevance of Olfactomedin 4 in Early-Stage Hepatocellular Carcinoma
21. Anschriften der Herausgeber und Autoren
22. The PI3K inhibitor copanlisib synergizes with sorafenib to induce cell death in hepatocellular carcinoma
23. Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET)
24. Relapse and Need for Extended Immunosuppression: Novel Features of Drug-Induced Autoimmune Hepatitis
25. Targeting cyclin dependent kinase 5 in hepatocellular carcinoma – A novel therapeutic approach
26. Signaling Pathways in Liver Diseases Kupffer Cells
27. Cell death markers in patients with cirrhosis and acute decompensation
28. Transarterial chemoembolization for hepatocellular carcinoma: development and external validation of the Munich-TACE score
29. Role of cysteinyl-leukotrienes for portal pressure regulation and liver damage in cholestatic rat livers
30. Kupffer Cells
31. COVID-19 and liver injury: hypoalbuminaemia and γGT should be observed at hospital admission
32. Functional relevance of the cannabinoid receptor 2 — heme oxygenase pathway: A novel target for the attenuation of portal hypertension
33. High age and low sodium urine concentration are associated with poor survival in patients with hepatorenal syndrome
34. Plasma cystatin C is a predictor of renal dysfunction, acute‐on‐chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis
35. Human monocyte-derived cells with individual hepatocyte characteristics: a novel tool for personalized in vitro studies
36. Challenges and Future of Drug-Induced Liver Injury Research—Laboratory Tests
37. Intraperitoneal LPS amplifies portal hypertension in rat liver fibrosis
38. Psychiatric and Psychosocial Outcome of Orthotopic Liver Transplantation
39. Marked Increase of Gamma-Glutamyltransferase as an Indicator of Drug-Induced Liver Injury in Patients without Conventional Diagnostic Criteria of Acute Liver Injury
40. Biomarkers of idiosyncratic drug-induced liver injury (DILI) - a systematic review
41. Drug-Induced Liver Injury (DILI): A Major Challenge
42. Albumin Might Attenuate Bacteria-Induced Damage on Kupffer Cells for Patients with Chronic Liver Disease
43. Secondary prophylaxis for variceal bleeding: carvedilol vs. propranolol
44. Acute Radiation Injury of Mice and the Influence of Sudden Time Shift
45. Novel predictors for liver transplantation or death in drug-induced acute liver failure
46. The Psychosocial Burden on Liver Transplant Recipients during the COVID-19 Pandemic
47. Ashwagandha-Induced Liver Injury: Self-Reports on Commercial Websites as Useful Adjunct Tools for Causality Assessment
48. A Simple Prognostic Scoring System for Hepatocellular Carcinoma Treated with Selective Internal Radiation Therapy
49. Biomarkers of idiosyncratic drug-induced liver injury (DILI) - a systematic review
50. Biomarkers of idiosyncratic drug-induced liver injury (DILI) - a systematic review
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.